Multipoint pacing is associated with reduction of heart failure hospitalizations or death in patients who do not respond to cardiac resynchronization therapy. Results of the MORE-CRT MPP randomized trial [0.03%]
多部位起搏与对心脏再同步治疗无反应的患者心力衰竭住院或死亡的减少有关。MORE-CRT MPP随机试验的结果
Christophe Leclercq,Haran Burri,Leonardo Calò et al.
Christophe Leclercq et al.
Background and aims: Cardiac resynchronization therapy (CRT) via biventricular pacing (BIVP) is an effective treatment, but non-responders are at higher risk of death and heart failure (HF) hospitalizations compared with ...
ESC Clinical Consensus Statement on Conduction System Pacing. With special contribution of the European Heart Rhythm Association (EHRA) of the ESC and endorsed by the Asia Pacific Heart Rhythm Society (APHRS), the Canadian Heart Rhythm Society (CHRS), the Heart Rhythm Society (HRS) and the Latin American Heart Rhythm Society (LAHRS) [0.03%]
ESC关于传导系统起搏的临床专家共识。特别贡献者为欧洲心律协会（EHRA），并得到亚太心脏节律学会（APHRS）、加拿大心律学会（CHRS）、心律学会（HRS）和拉丁美洲心脏节律学会（LAHRS）的认可
Michael Glikson,Haran Burri,Amr Abdin et al.
Michael Glikson et al.
Conduction system pacing is being increasingly adopted as a more physiological alternative to right ventricular and biventricular pacing. Since the 2021 European Society of Cardiology pacing guidelines, there has been growing evidence that ...
Lifestyle and risk factor modification in atrial fibrillation: A European Heart Rhythm Association survey [0.03%]
房颤的生活方式和危险因素改善：一项欧洲心律协会调查
Mark T Mills,Piotr Futyma,Peter Calvert et al.
Mark T Mills et al.
Aims: Lifestyle and risk factor modification (LRFM) forms a central pillar in the management of atrial fibrillation (AF). This European Heart Rhythm Association (EHRA) survey aims to assess current clinical practice regar...
Acute ischemic stroke during high-power short-duration ablation for atrial fibrillation patients: a case series study [0.03%]
房颤患者进行高功率短时间消融术过程中发生急性缺血性卒中：系列病例研究
Xiaofeng Lu,Xintao Li,Yong Lu et al.
Xiaofeng Lu et al.
Flecainide acetate inhalation solution for cardioversion of recent-onset, symptomatic atrial fibrillation: results of the phase 3 RESTORE-1 trial [0.03%]
丙吡胺醋酸酯吸入液用于近期发作、有症状的房颤转复的成功率：III期RESTORE-1试验的结果
Michiel Rienstra,Anderson C Woite-Silva,Aaf Kuijper et al.
Michiel Rienstra et al.
Background and aims: Atrial fibrillation (AF) is the most prevalent cardiac arrhythmia. New treatments are needed to cardiovert recent-onset paroxysmal AF quickly and safely. RESTORE-1 was a multicentre, randomised, doubl...
Sensing and Detection Performance of the Novel, Small-diameter OmniaSecure Defibrillation Lead: In-depth analysis from the LEADR Trial [0.03%]
新型小直径OmniaSecure除颤导线的感应和检测性能：来自LEADR试验的深入分析
Prashanthan Sanders,Pamela K Mason,Bert Hansky et al.
Prashanthan Sanders et al.
Background: The Lead EvaluAtion for Defibrillation and Reliability (LEADR) trial evaluated the small-diameter (4.7Fr), integrated bipolar OmniaSecure defibrillation lead. As previously reported, the trial exceeded primary...
Sex Differences in the Risk of Readmission for Ventricular Arrhythmia following Myocardial Infarction in Patients without Implantable Cardioverter-Defibrillator: A Nationwide Cohort Study [0.03%]
心肌梗死后未植入心脏除颤器患者室性心律失常再次住院的性别差异：一项全国队列研究
Charles Guenancia,Jean-Marc Sellal,Nefissa Hammache et al.
Charles Guenancia et al.
Andrea Vincon
Andrea Vincon
Biventricular vs. right ventricular pacing devices in patients anticipated to require frequent ventricular pacing (BioPace) [0.03%]
双心室与右心室起搏器在预期需要频繁心室起搏的患者中的应用（BioPace）
Reinhard C Funck,Hans-Helge Müller,Maurizio Lunati et al.
Reinhard C Funck et al.
Aims: Right ventricular (RV) pacing may promote left ventricular (LV) dysfunction. Particularly in patients with preserved LV ejection fraction (LVEF), narrow QRS, and anticipated high ventricular pacing burden (HVPB), ev...
Randomized Controlled Trial
Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology. 2025 Mar 5;27(3):euaf029. DOI:10.1093/europace/euaf029 2025
How harmful is right ventricular pacing? The question revived by the BioPace trial [0.03%]
右心室起搏有多大危害？BioPace试验重启的问题
Mads Brix Kronborg,Niraj Varma,Jens Cosedis Nielsen
Mads Brix Kronborg